Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 3
1986 7
1987 4
1988 7
1989 9
1990 2
1991 6
1993 2
1994 1
1995 1
1996 3
1997 1
1998 4
1999 3
2001 2
2002 5
2003 3
2004 2
2005 1
2006 1
2007 2
2009 1
2010 3
2011 2
2012 2
2013 1
2014 4
2015 4
2016 3
2017 3
2018 2
2019 5
2020 5
2021 4
2022 6
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Blanco B, Ramírez-Fernández Á, Bueno C, Argemí-Muntadas L, Fuentes P, Aguilar-Sopeña Ó, Gutierrez-Agüera F, Zanetti SR, Tapia-Galisteo A, Díez-Alonso L, Segura-Tudela A, Castellà M, Marzal B, Betriu S, Harwood SL, Compte M, Lykkemark S, Erce-Llamazares A, Rubio-Pérez L, Jiménez-Reinoso A, Domínguez-Alonso C, Neves M, Morales P, Paz-Artal E, Guedan S, Sanz L, Toribio ML, Roda-Navarro P, Juan M, Menéndez P, Álvarez-Vallina L. Blanco B, et al. Among authors: toribio ml. Cancer Immunol Res. 2022 Apr 1;10(4):498-511. doi: 10.1158/2326-6066.CIR-21-0853. Cancer Immunol Res. 2022. PMID: 35362043 Free PMC article.
Human T-ALL Xenografts.
Fuentes P, Toribio ML, González-García S. Fuentes P, et al. Among authors: toribio ml. Methods Mol Biol. 2021;2185:215-239. doi: 10.1007/978-1-0716-0810-4_13. Methods Mol Biol. 2021. PMID: 33165851
Modeling altered human T-cell development.
Toribio ML. Toribio ML. Blood. 2016 Aug 11;128(6):743-5. doi: 10.1182/blood-2016-06-723908. Blood. 2016. PMID: 27516425 Free article. No abstract available.
Early T-cell development.
Gutierrez-Ramos JC, Toribio ML, Martinez C. Gutierrez-Ramos JC, et al. Among authors: toribio ml. Nature. 1993 Jan 21;361(6409):213. doi: 10.1038/361213a0. Nature. 1993. PMID: 8423850 No abstract available.
γδ T Lymphocytes in the Diagnosis of Human T Cell Receptor Immunodeficiencies.
Garcillán B, Marin AV, Jiménez-Reinoso A, Briones AC, Muñoz-Ruiz M, García-León MJ, Gil J, Allende LM, Martínez-Naves E, Toribio ML, Regueiro JR. Garcillán B, et al. Among authors: toribio ml. Front Immunol. 2015 Jan 29;6:20. doi: 10.3389/fimmu.2015.00020. eCollection 2015. Front Immunol. 2015. PMID: 25688246 Free PMC article. Review. No abstract available.
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.
Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P, Muñoz-Calleja C, Toribio ML, Kremer L, Garcia-Sanz JA. Santamaria S, et al. Among authors: toribio ml. Front Immunol. 2022 Jul 27;13:825635. doi: 10.3389/fimmu.2022.825635. eCollection 2022. Front Immunol. 2022. PMID: 35967322 Free PMC article.
[Immunotherapy with CAR-T cells in paediatric haematology-oncology].
Mirones I, Moreno L, Patiño-García A, Lizeaga G, Moraleda JM, Toribio ML, Pérez-Martínez A; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Española de Hematología y Oncología Pediátricas; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Española de Hematología y Oncología Pediátricas. Mirones I, et al. Among authors: toribio ml. An Pediatr (Engl Ed). 2020 Jul;93(1):59.e1-59.e10. doi: 10.1016/j.anpedi.2019.12.014. Epub 2020 Feb 24. An Pediatr (Engl Ed). 2020. PMID: 32107177 Free article. Spanish.
112 results